Osmotica Pharmaceuticals plchttps://pcaobus.org/form-ap-filings/39146/39146Osmotica Pharmaceuticals plc391464/16/2019 12:22:31 PM201882f3da45-eb2f-4c46-a6ab-139b3b9286a3243BDO USA, LLP722223Osmotica Pharmaceuticals plc1739426OSMT0024311809Matthew Lawrence Riviello0024311809True
ContraVir Pharmaceuticals, Inc.https://pcaobus.org/form-ap-filings/35401/35401ContraVir Pharmaceuticals, Inc.354013/18/2019 2:39:48 PM2018c29a3654-f59b-4cf2-acdb-3d1ddab0fa99243BDO USA, LLP565730ContraVir Pharmaceuticals, Inc.1583771HEPA0024311809Matthew Lawrence Riviello0024311809True
Anavex Life Sciences Corp.https://pcaobus.org/form-ap-filings/31638/31638Anavex Life Sciences Corp.3163812/20/2018 1:38:57 PM20181969045d-939e-413c-a2d2-6e8d5d256e85243BDO USA, LLP300987Anavex Life Sciences Corp.1314052AVXL0024311809Matthew Lawrence Riviello0024311809True
Osmotica Pharmaceuticals plchttps://pcaobus.org/form-ap-filings/29525/29525Osmotica Pharmaceuticals plc295259/23/2018 5:52:11 AM20183b4dc984-ce33-49af-b62d-d6be4a0e76fd243BDO USA, LLP722223Osmotica Pharmaceuticals plc1739426OSMT0024311809Matthew Lawrence Riviello0024311809True
CONTRAVIR PHARMACEUTICALS, INC.https://pcaobus.org/form-ap-filings/21092/21092CONTRAVIR PHARMACEUTICALS, INC.210923/30/2018 1:39:46 PM2017cfa290cc-6041-41a3-a8b7-c0c6aa9b534e243BDO USA, LLP565730CONTRAVIR PHARMACEUTICALS, INC.1583771HEPA0024311809Matthew Lawrence Riviello0024311809True